BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20837367)

  • 1. Prognostic impact of atrial fibrillation progression in a community study: AFBAR Study (Atrial Fibrillation in the Barbanza Area Study).
    García-Castelo A; García-Seara J; Otero-Raviña F; Lado M; Vizcaya A; Vidal JM; Lafuente R; Bouza D; Lear PV; González-Juanatey JR;
    Int J Cardiol; 2011 Nov; 153(1):68-73. PubMed ID: 20837367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The change in the atrial fibrillation type as a prognosis marker in a community study: long-term data from AFBAR (Atrial Fibrillation in the BARbanza) study.
    Vidal-Perez R; Otero-Raviña F; Lado-López M; Turrado-Turrado V; Rodríguez-Moldes E; Gómez-Vázquez JL; de Frutos-de Marcos C; de Blas-Abad P; Besada-Gesto R; Gonzalez-Juanatey JR;
    Int J Cardiol; 2013 Oct; 168(3):2146-52. PubMed ID: 23452888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy.
    De Vos CB; Breithardt G; Camm AJ; Dorian P; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Crijns HJ
    Am Heart J; 2012 May; 163(5):887-93. PubMed ID: 22607868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].
    Scardi S; Mazzone C; Goldstein D; Pandullo C; Poletti A; Humar F; Pivotti F; De Santis C
    G Ital Cardiol; 1995 Feb; 25(2):173-82. PubMed ID: 7642022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study.
    Miyasaka Y; Barnes ME; Bailey KR; Cha SS; Gersh BJ; Seward JB; Tsang TS
    J Am Coll Cardiol; 2007 Mar; 49(9):986-92. PubMed ID: 17336723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
    Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ
    J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
    J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation.
    Letsas KP; Weber R; Bürkle G; Mihas CC; Minners J; Kalusche D; Arentz T
    Europace; 2009 Feb; 11(2):158-63. PubMed ID: 19010799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes for patients with ischaemic stroke and atrial fibrillation: the PRISM study (A Program of Research Informing Stroke Management).
    Gattellari M; Goumas C; Aitken R; Worthington JM
    Cerebrovasc Dis; 2011; 32(4):370-82. PubMed ID: 21921601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of atrial fibrillation in acute coronary syndromes.
    Torres M; Rocha S; Marques J; Nabais S; Rebelo A; Pereira MA; Azevedo P; Correia A
    Rev Port Cardiol; 2008 Nov; 27(11):1407-18. PubMed ID: 19227808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study.
    Emilsson L; Smith JG; West J; Melander O; Ludvigsson JF
    Eur Heart J; 2011 Oct; 32(19):2430-7. PubMed ID: 21653560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).
    Friberg L; Hammar N; Rosenqvist M
    Heart; 2010 Feb; 96(4):275-80. PubMed ID: 19710030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline characteristics of patients from Poland enrolled in the global registry of patients with recently diagnosed atrial fibrillation (RecordAF).
    Opolski G; Kosior DA; Kurzelewski M; Skrzyńska M; Zagórski A; Janion M; Muzolf M; Wlazłowski R; Pankiewicz B; Łoboz-Grudzień K; Breithardt G;
    Kardiol Pol; 2010 May; 68(5):546-54. PubMed ID: 20491018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP Study.
    Otero-Raviña F; Grigorian-Shamagian L; Fransi-Galiana L; Názara-Otero C; Fernández-Villaverde JM; del Alamo-Alonso A; Nieto-Pol E; de Santiago-Boullón M; López-Rodríguez I; Cardona-Vidal JM; Varela-Román A; González-Juanatey JR;
    Int J Cardiol; 2009 Jul; 136(1):56-63. PubMed ID: 18617282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure.
    Beukema WP; Sie HT; Misier AR; Delnoy PP; Wellens HJ; Elvan A
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):771-5. PubMed ID: 18768326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation.
    Berruezo A; Tamborero D; Mont L; Benito B; Tolosana JM; Sitges M; Vidal B; Arriagada G; Méndez F; Matiello M; Molina I; Brugada J
    Eur Heart J; 2007 Apr; 28(7):836-41. PubMed ID: 17395676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.